Free Trial

Zacks Research Issues Negative Outlook for MRSH Earnings

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research cut its Q2 2026 EPS estimate for Marsh & McLennan to $2.88 from $2.93 and projects FY2027 EPS of $11.19, while the current full‑year consensus sits at $10.36.
  • Several brokers have trimmed price targets (JPMorgan, Barclays among them) and MarketBeat shows a consensus rating of Hold with a $205.33 price target; MRSH recently traded near $167.30 (1‑year range $164.89–$235.78) with a market cap of ~$80.6B and a P/E of 20.91.
  • Operationally, MMCo. beat Q1 estimates (EPS $3.29 vs. $3.21) with revenue up 7.6% YoY, declared a $0.90 quarterly dividend (3.60 annualized, ~2.2% yield), and CEO John Q. Doyle sold 16,655 shares, a ~12.48% reduction in his holdings.
  • Five stocks to consider instead of Marsh & McLennan Companies.

Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) - Investment analysts at Zacks Research reduced their Q2 2026 earnings estimates for shares of Marsh & McLennan Companies in a note issued to investors on Thursday, April 30th. Zacks Research analyst Team now expects that the financial services provider will post earnings per share of $2.88 for the quarter, down from their previous forecast of $2.93. The consensus estimate for Marsh & McLennan Companies' current full-year earnings is $10.36 per share. Zacks Research also issued estimates for Marsh & McLennan Companies' Q1 2027 earnings at $3.44 EPS, Q4 2027 earnings at $2.61 EPS and FY2027 earnings at $11.19 EPS.

A number of other analysts also recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research report on Thursday, April 9th. Evercore reduced their target price on Marsh & McLennan Companies from $237.00 to $236.00 and set an "outperform" rating on the stock in a research note on Wednesday, January 7th. Cantor Fitzgerald increased their target price on Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an "overweight" rating in a research note on Monday, February 2nd. Citigroup increased their target price on Marsh & McLennan Companies from $201.00 to $205.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 3rd. Finally, Barclays reduced their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $205.33.

View Our Latest Stock Report on Marsh & McLennan Companies

Marsh & McLennan Companies Price Performance

MRSH stock opened at $167.30 on Monday. Marsh & McLennan Companies has a 1-year low of $164.89 and a 1-year high of $235.78. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market cap of $80.60 billion, a P/E ratio of 20.91, a price-to-earnings-growth ratio of 2.45 and a beta of 0.65. The business has a 50 day simple moving average of $173.34.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last posted its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. The business's revenue for the quarter was up 7.6% on a year-over-year basis.

Marsh & McLennan Companies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, April 9th. This represents a $3.60 dividend on an annualized basis and a yield of 2.2%. Marsh & McLennan Companies's dividend payout ratio (DPR) is presently 45.00%.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 16,655 shares of the firm's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer owned 116,811 shares of the company's stock, valued at $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.38% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of institutional investors have recently added to or reduced their stakes in MRSH. Pinnacle Bancorp Inc. purchased a new stake in shares of Marsh & McLennan Companies during the third quarter worth about $25,000. Headlands Technologies LLC purchased a new stake in shares of Marsh & McLennan Companies during the second quarter worth about $29,000. Solstein Capital LLC purchased a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $25,000. SHP Wealth Management purchased a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $26,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $27,000. Institutional investors own 87.99% of the company's stock.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

See Also

Earnings History and Estimates for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines